Acta Diabetologica

, Volume 49, Supplement 1, pp 99–105 | Cite as

Failure of glycated hemoglobin drop after continuous subcutaneous insulin infusion initiation may indicate patients who discontinue: a 4-year follow-up study in children and adolescents with type 1 diabetes

  • Fortunato Lombardo
  • Andrea E. Scaramuzza
  • Dario Iafusco
Original Article

Abstract

Continuous subcutaneous insulin infusion (CSII) is effective and safe in children and adults with type 1 diabetes. Notwithstanding, some patients decide to discontinue using CSII. We evaluated the discontinuation rate, and its related factors, in a large group of children and adolescents with type 1 diabetes using CSII in Italy. Data on all patients with type 1 diabetes younger than 18 years were collected by 28 Pediatric Diabetologic referral Centers located throughout Italy. The primary endpoint was to measure the discontinuation rate using CSII. Among the study population (n = 6,644), 985 (14.8%) were using CSII. Sixty patients discontinued using CSII, representing the 6.1%. The discontinuation rate significantly increased (P = 0.002) with age: 0–6 years, 1/84 (1.2%), 7–11 years, 8/262 (3.1%), 12–18 years, 51/579 (8.8%). The average time to discontinuation was 1.8 ± 1.4 years. The average age of patients who discontinued using CSII was higher than in patients still on CSII (12.1 ± 3.2 vs. 10.3 ± 3.8, P = 0.0001), while their diabetes duration was significantly shorter (8.6 ± 2.7 vs. 10.2 ± 3.7, P = 0.0001). HbA1c decreased only in patients still on CSII (8.7 ± 1.3% vs. 7.8 ± 1.3%, P = 0.02), but not in patients who discontinued using CSII (8.5 ± 1.6% vs. 8.2 ± 1.3%, P = 0.213). HbA1c might be one important indicator helpful to identify patients at higher risk discontinuing using CSII.

Keywords

Adolescents Children Continuous subcutaneous insulin infusion Discontinuation Insulin pump therapy Type 1 diabetes 

References

  1. 1.
    Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R (2003) Insulin pump therapy: a meta-analysis. Diabetes Care 26:1079–1087PubMedCrossRefGoogle Scholar
  2. 2.
    Plotnick LP, Clark LM, Brancati FL, Erlinger T (2003) Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 26:1142–1146PubMedCrossRefGoogle Scholar
  3. 3.
    Nahata L (2006) Insulin therapy in pediatric patients with type I diabetes: continuous subcutaneous insulin infusion versus multiple daily injections. Clin Pediatr 45:765–774CrossRefGoogle Scholar
  4. 4.
    Ludvigsson J, Samuelsson U (2007) Continuous insulin infusion (CSII) or modern type of multiple daily injections (MDI) in diabetic children and adolescents: a critical review on a controversial issue. Pediatr Endocrinol Rev 5:666–678PubMedGoogle Scholar
  5. 5.
    Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, Siebenhofer A (2008) Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 51:941–951PubMedCrossRefGoogle Scholar
  6. 6.
    Pańkowska E, Błazik M, Dziechciarz P, Szypowska A, Szajewska H (2009) Continuous subcutaneous insulin infusion vs multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes 10:52–58PubMedCrossRefGoogle Scholar
  7. 7.
    Bruttomesso D, Costa S, Baritusso A (2009) Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy. Diabetes Metab Res Rev 25:99–111PubMedCrossRefGoogle Scholar
  8. 8.
    Pickup JC, Sutton AJ (2008) Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 25:765–774PubMedCrossRefGoogle Scholar
  9. 9.
    Monami M, Lamanna C, Marchionni N, Mannucci E (2010) Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis. Acta Diabetol 47(suppl 1):S77–S81CrossRefGoogle Scholar
  10. 10.
    Colino E, Alvarez MA, Carcavilla A, Alonso M, Ros P, Barrio R (2010) Insulin dose adjustment when changing from multiple daily injections to continuous subcutaneous insulin infusion in the pediatric age group. Acta Diabetol 47(suppl 1):S1–S6CrossRefGoogle Scholar
  11. 11.
    Phillip M, Battelino T, Rodriguez H, Danne T, Kaufman F; European Society for Paediatric Endocrinology; Lawson Wilkins Pediatric Endocrine Society; International Society for Pediatric and Adolescent Diabetes; American Diabetes Association (2007) European Association for the study of diabetes: use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 30:1653–1662Google Scholar
  12. 12.
    Wood JR, Moreland EC, Volkening LK, Svoren BM, Butler DA, Laffel LBM (2006) Durability of insulin pump use in pediatric patients with type 1 diabetes. Diabetes Care 29:2355–2360PubMedCrossRefGoogle Scholar
  13. 13.
    Ronsin O, Jannot-Lamotte MF, Vague P, Lassman-Vague V (2005) Factors related to CSII compliance. Diabetes Metab 31:90–95PubMedCrossRefGoogle Scholar
  14. 14.
    Schifferdecker E, Schmidt K, Boehm BO, Schatz H (1994) Long-term compliance of intensified insulin therapy. Diabetes Res Clin Pract 23:17–23PubMedCrossRefGoogle Scholar
  15. 15.
    Floyd JC Jr, Cornell RG, Jacober SJ, Griffith LE, Funnell MM, Wolf LL, Wolf FM (1993) A prospective study identifying risk factors for discontinuance of insulin pump therapy. Diabetes Care 16:1470–1478PubMedCrossRefGoogle Scholar
  16. 16.
    Guinn TS, Bailey GJ, Mecklenburg RS (1988) Factors related to discontinuation of continuous subcutaneous insulin-infusion therapy. Diabetes Care 11:46–51PubMedCrossRefGoogle Scholar
  17. 17.
    Rabbone I, Iafusco D, Toni S, Lombardo F, Lorini R, Italian Study Group on Diabetes of Italian Society Pediatric of Endocrinology and Diabetology (ISPED) (2010) Italian (retrospective) survey on continuous subcutaneous insulin infusion (CSII) therapy in children and adolescents with type 1 diabetes mellitus. Infusystem International 9:9–13Google Scholar
  18. 18.
    Hofer SE, Heidtmann B, Raile K, Fröhlich-Reiterer E, Lilienthal E, Berghaeuser MA, Holl RW, DPV-Science-Initiative and the German working group for insulin pump treatment in pediatric patients (2010) Discontinuation of insulin pump treatment in children, adolescents, and young adults. A multicenter analysis based on the DPV database in Germany and Austria. Pediatr Diabetes 11:116–121PubMedCrossRefGoogle Scholar
  19. 19.
    Bell DS, Ackerson C, Cutter G, Clements RS Jr (1988) Factors associated with discontinuation of continuous subcutaneous insulin infusion. Am J Med Sci 295:23–28PubMedCrossRefGoogle Scholar
  20. 20.
    Knight G, Boulton AJM, Ward JD (1986) Experience of continuous subcutaneous insulin infusion in the outpatient management of diabetic teenagers. Diabetes Care 3:82–84Google Scholar
  21. 21.
    Brink SJ, Stewart C (1986) Insulin pump treatment in insulin-dependent diabetes mellitus. Children, adolescents, and young adults. JAMA 255:617–622PubMedCrossRefGoogle Scholar
  22. 22.
    de Vries L, Grushka Y, Lebenthal Y, Shalitin S, Phillip M (2010) Factors associated with increased risk of insulin pump discontinuation in pediatric patients with type 1 diabetes. Pediatr Diabetes Aug 15 [Epub ahead of print]Google Scholar
  23. 23.
    Scaramuzza A, Iafusco D, Lombardo F, Rabbone I, Toni S, Italian Society of Paediatric Endocrinology and Diabetology (2008) Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year food and drug administration retrospective study of adverse events. Pediatrics 122:473–474PubMedCrossRefGoogle Scholar
  24. 24.
    Pinelli L, Rabbone I, Salardi S, Toni S, Scaramuzza A, Bonfanti R, Cherubini V, Franzese A, Frongia AP, Lafusco D, Sulli N, Tumini S, Curto O, Miassimelli M, Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology (2008) Insulin pump therapy in children and adolescents with type 1 diabetes: the Italian viewpoint. Acta Biomed 79:57–64PubMedGoogle Scholar
  25. 25.
    Havelka M, Lucanin JD, Lucanin D (2009) Biopsychosocial model—the integrated approach to health and disease. Coll Antropol 33:303–310PubMedGoogle Scholar
  26. 26.
    Malik JA, Koot HM (2009) Explaining the adjustment of adolescents with type 1 diabetes: role of diabetes-specific and psychosocial factors. Diabetes Care 32:774–779PubMedCrossRefGoogle Scholar
  27. 27.
    Hasken J, Kresl L, Nydegger T, Temme M (2010) Diabulimia and the role of school health personnel. J Sch Health 80:465–469PubMedCrossRefGoogle Scholar
  28. 28.
    Iafusco D, Vanelli M, Gugliotta M, Iovane B, Chiari G, Prisco F (2004) Prevalence of eating disorders in young patients with type 1 diabetes from two different Italian cities. Diabetes Care 27:2278PubMedCrossRefGoogle Scholar
  29. 29.
    Iafusco D, Confetto S, Prisco F, Lombardo F, Salzano G, De Luca F (2006) The egg or the chicken? Should good compliance to multi-injection insulin therapy be a criterion for insulin pump therapy, or does insulin pump therapy improve compliance? J Pediatr 148:421PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Fortunato Lombardo
    • 1
  • Andrea E. Scaramuzza
    • 2
  • Dario Iafusco
    • 3
  1. 1.Department of Pediatric SciencesUniversity of MessinaMessinaItaly
  2. 2.Department of Pediatrics, Azienda OspedalieraUniversity of MilanMilanoItaly
  3. 3.Department of PediatricsSecond University of NaplesNaplesItaly

Personalised recommendations